Marijuana Legalization Is A ‘Significant Threat’ To Alcohol Industry Because People Substitute Cannabis For Beer And Wine, Analysis Finds

Financial analysts say they expect the expansion of the marijuana legalization movement will continue to post a “significant threat” to the alcohol industry, citing survey data that suggests more people are using cannabis as a substitute for alcoholic beverages such a beer and wine. A report from Bloomberg Intelligence (BI) projects that slumping sales of

Read More

Study: Adverse delta-8 THC incidents higher in states without legal cannabis

States that prohibit marijuana use are experiencing significantly higher rates of adverse events related to delta-8 THC products, according to a new study published in the Journal of Medical Toxicology. Researchers from Ohio State University’s College of Medicine analyzed 4,925 incidents involving delta-8 THC reported to U.S. poison control centers …

Read More

Wisconsin tribes launch lobbying campaign for medical marijuana

One of the few Midwestern states remaining without legal medical or recreational marijuana, Wisconsin now has a formal political campaign dedicated to rectifying that, by lobbying state lawmakers to approve medical cannabis. And the new campaign is being spearheaded by Native American tribes, The Daily Cardinal reported. The Indigenous Cannabis …

Read More

Alabama judge considers revising order that’s stalled medical marijuana licensing

A Montgomery County Circuit Court judge is considering revising a temporary restraining order that has kept the issuance of medical marijuana business licenses in limbo. But what that change would entail is still unknown. Judge James Anderson on Tuesday heard arguments from attorneys representing the Alabama Medical Cannabis Commission and …

Read More

IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate

IGC Pharma Inc. (NYSE: IGC), which was formerly known as India Globalization Capital, announced Wednesday it plans to advance its drug candidate IGC-AD1 into clinical trials as a potential anti-amyloid treatment for Alzheimer’s disease. The move follows recent FDA approvals of anti-amyloid drugs from Eli Lilly and Eisai/Biogen, signaling growing …

Read More

Whitney Economics slashes U.S. hemp acreage forecast by 82%

Cannabis and hemp business consulting firm Whitney Economics has dramatically reduced its 2030 forecast for U.S. hemp grain and fiber acreage, citing regulatory uncertainties and infrastructural challenges. The firm now projects 1 million acres by 2030, down 82% from its previous estimate. The revision could translate to approximately $3.1 billion …